Filing Details
- Accession Number:
- 0000059478-19-000155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-16 14:36:52
- Reporting Period:
- 2019-04-12
- Accepted Time:
- 2019-04-16 14:36:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1566364 | S Melissa Barnes | Lilly Corporate Center Indianapolis IN 46285 | Chief Eth/Cmpl Ofcr & Svp, Erm | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-04-12 | 4,735 | $125.15 | 22,085 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-03-15 | 1,815 | $0.00 | 20,270 | No | 4 | G | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | G | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 897 | Indirect | 401(k) |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019.